Status:

COMPLETED

Clinical Assessment of Pidogrel® Versus Plavix® (CAPP)

Lead Sponsor:

Les Laboratoires des Médicaments Stériles

Conditions:

Coronary Disease

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

This study aims to demonstrate non-inferiority of Pidogrel ® compared to Plavix ® in patients with coronary disease: * Primary Outcome Measures: measure of platelet reactivity by VerifyNow assay afte...

Detailed Description

after randomization of patients in both groups (Plavix or Pidogrel), the measure of platelet activity by the VerifyNow assay, 4 to 12 hours after the loading dose of 600mg or after the last dose of cl...

Eligibility Criteria

Inclusion

  • Male or female,
  • Old (e) over 20 years
  • Patients hospitalized for acute coronary syndrome (Whatever the T and troponin)
  • Patients with proven coronary candidates for treatment with clopidogrel (who received a loading dose of 600mg over 2 hours and treated with 75mg / d of clopidogrel for longer than 7 days)

Exclusion

  • Patients unwilling.
  • Patient participating in another study.
  • Patients with cardiogenic shock
  • Patient on anti GpIIbIIIa or stopped less than 72 hours before the test aggregability
  • Patients scheduled for surgery in less than 6 months.
  • Patients candidates for coronary angioplasty
  • Patients who underwent TAC + / - bare stent fewer than 30 days.
  • Patients who underwent stenting with ATC active there is less than 12 months.
  • ischemic stroke older than 6 weeks.
  • History of hemorrhagic stroke (any time)
  • Patients on warfarin or candidates
  • Patients with a different anti ADP (ticlopidine, prasugrel)
  • Patients with indication for clopidogrel-cons (side effects, bleeding ...)
  • Thrombocytopenia \<100000/mm3
  • anemia (Ht \<30%)
  • Thrombocythaemia (Ht\> 52%)
  • Patients seeking treatment for an elective forms of Clopidogrel.
  • Pregnancy

Key Trial Info

Start Date :

April 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2011

Estimated Enrollment :

219 Patients enrolled

Trial Details

Trial ID

NCT01431495

Start Date

April 1 2010

End Date

July 1 2011

Last Update

September 9 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

cardiology department, hospital La RABTA

Tunis, Tunis BAB Souika, Tunisia, 1007